EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Early Occurrence of Heart Failure Hospitalization or Ventricular Arrhythmia Re-Define the Long-Term Prognosis After CRT

Anna Zsofia Toth iD, Laszlo Nagy, Krisztina Maria Szabo, Vivien Racz, Alexandra Kiss, Gabor Sandorfi, Attila Borbely, Tibor Laszlo Nagy, Zoltan Csanadi

ESC Heart Failure · 2025

DOI: 10.1002/ehf2.15274 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ESC Heart Failure, 2025. Verfasst von Anna Zsofia Toth und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Division of Cardiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary. Hauptthemen laut MEDLINE: Heart Failure, Cardiac Resynchronization Therapy, Hospitalization, Ventricular Function, Left. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Research, Development and Innovation Fund, Nemzeti Kutatási, Fejlesztési és Innovaciós Alap.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Classifying patients as responders or non-responders to cardiac resynchronization therapy (CRT) has been recently challenged, suggesting that preventing heart failure (HF) progression may also provide survival benefits. We assessed a novel classification based on echocardiographic left ventricular (LV) reverse remodelling and the occurrence of acute HF hospitalization (HHF) or sustained ventricular arrhythmia (VA) within 1-year post-CRT. Methods and results Patients implanted with a CRT defibrillator (CRT-D) at our department between 2010 and 2020 were classified based on the change in LV ejection fraction (LVEF) within 1 year as responders (increase ≥ 10%), non-progressors (increase <10%) or progressors (decline). Patients in each category were further divided based on the occurrence or absence of an HHF/VA event within 1-year post-implantation. Long-term survival free of heart transplantation or LV assist device implantation was calculated for all six subgroups. Cohorts demonstrating no significant between-group differences were grouped together and reclassified as improved, stabilized or worsened. One hundred nineteen responders, 79 non-progressors and 69 progressors were identified based on the echocardiographic response. Long-term event-free survival was higher for responders as compared with non-progressors (hazard ratio [HR] 0.51, P = 0.002) or progressors (HR 0.34, P < 0.0001). Furthermore, non-progressors had better outcome than progressors (HR 0.63, P = 0.03). Long-term prognosis in patients was superior with versus without an HHF/VA event within each group of responders (HR 0.47, P = 0.03), non-progressors (HR 0.31, P = 0.0001) or progressors (HR 0.38, P = 0.0004). No survival difference was found between responders and non-progressors with no event (HR 0.69, P = 0.09), who were recategorized as improved. Long-term prognosis was also similar in responders with any event and in progressors with no event (HR 0.98, P = 0.88; stabilized), as well as in non-progressors and progressors with any event (HR 0.87, P = 0.63; worsened). Median survival rates demonstrated significant differences between the improved, stabilized and worsened groups (102.3, 62.0 and 24.4 months; HR 0.53, P = 0.006 between improved and stabilized; HR 0.41, P < 0.0001 between stabilized and worsened; HR 0.21, P < 0.0001 between improved and worsened cohorts, respectively).

Conclusions

Long-term survival can be predicted based on the change in LVEF and on the occurrence of an HHF/VA event within 1-year after CRT-D implantation. Stabilized patients have significantly better prognosis as compared with the worsened group. Patients with strikingly poor prognosis can be identified using this assessment method.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureCardiac Resynchronization TherapyHospitalizationVentricular Function, LeftVentricular RemodelingArrhythmias, CardiacHumansMaleFemalePrognosisAgedMiddle AgedStroke VolumeRetrospective StudiesFollow-Up StudiesTime FactorsEchocardiographySurvival Rate

Stichwörter der Autor:innen

CRT non‐responderCardiac resynchronization therapy (CRT)non‐progressorprogressor

Autor:innen und Institutionen

  • Department of Cardiology, Division of Cardiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.

ORCID-Profile: Anna Zsofia Toth

Förderung

  • National Research, Development and Innovation Fund
  • Nemzeti Kutatási, Fejlesztési és Innovaciós Alap

Zitieren

APA

Toth, A. Z., Nagy, L., Szabo, K. M., Racz, V., Kiss, A., Sandorfi, G., Borbely, A., Nagy, T. L., & Csanadi, Z. (2025). Early Occurrence of Heart Failure Hospitalization or Ventricular Arrhythmia Re-Define the Long-Term Prognosis After CRT. ESC Heart Failure. https://doi.org/10.1002/ehf2.15274

Vancouver

Toth AZ, Nagy L, Szabo KM, Racz V, Kiss A, Sandorfi G, et al. Early Occurrence of Heart Failure Hospitalization or Ventricular Arrhythmia Re-Define the Long-Term Prognosis After CRT. ESC Heart Failure. 2025. doi:10.1002/ehf2.15274

BibTeX
@article{Toth2025,
  author = {Toth, Anna Zsofia and Nagy, Laszlo and Szabo, Krisztina Maria and Racz, Vivien and Kiss, Alexandra and Sandorfi, Gabor and Borbely, Attila and Nagy, Tibor Laszlo and Csanadi, Zoltan},
  title = {Early Occurrence of Heart Failure Hospitalization or Ventricular Arrhythmia Re-Define the Long-Term Prognosis After CRT},
  journal = {ESC Heart Failure},
  year = {2025},
  doi = {10.1002/ehf2.15274}
}
Kostenlos starten →